The drug works to prevent strokes in people with a heart-rhythm disorder called atrial fibrillation. An FDA decision could come as early as March 28, 2012.
Related Articles on FDA Approvals:
FDA Approves Expansion of BioMarin Pharma Plant
FDA Approves Philips’ PET and MRI Whole Body Scanning System
FDA Approves New Boston Scientific Heart Stent
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.